Vireo Growth (VREOF) Other Non-Current Liabilities (2021 - 2026)

Vireo Growth's (VREOF) quarterly Other Non-Current Liabilities came in at $30.0 million in Q1 2026, up 80376.42% year-on-year from N/an in Q1 2025, and up 1400.0% quarter-over-quarter from $2.0 million in Q4 2025.

Vireo Growth (VREOF) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Vireo Growth has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $30.0 million for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $30.0 million, up 80376.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.0 million (up 80376.42% YoY), and the FY2025 annual result was $2.0 million, changed N/A from the prior year.
  • Other Non-Current Liabilities came in at $30.0 million for Q1 2026 at Vireo Growth, up from $2.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $30.0 million in Q1 2026 to a low of $1613.0 in Q4 2022.
  • The 5-year median for Other Non-Current Liabilities is $205917.5 (2023), against an average of $3.4 million.
  • Across the five-year window, Other Non-Current Liabilities slumped 78.85% in 2025 and surged 80376.42% in 2026, its largest moves.
  • Vireo Growth's Other Non-Current Liabilities stood at $1613.0 in 2022, then surged by 7454.0% to $121846.0 in 2023, then surged by 61.35% to $196598.0 in 2024, then jumped by 917.3% to $2.0 million in 2025, then soared by 1400.0% to $30.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $30.0 million (Q1 2026), $2.0 million (Q4 2025), and $1.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Vireo Growth - - 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 30.00 Mn
Dec 31, 2025 2.00 Mn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 37,278.00
Jun 30, 2024 196,598.00
Mar 31, 2024 176,257.00
Dec 31, 2023 121,846.00
Sep 30, 2023 235,577.00
Jun 30, 2023 215,237.00
Dec 31, 2022 1,613.00
Sep 30, 2021 3.08 Mn
Jun 30, 2021 3.71 Mn
Mar 31, 2021 5.24 Mn